Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination product containing fluticasone propionate, a synthetic glucocorticoid corticosteroid, and ginkgo biloba extract, an herbal supplement derived from the leaves of the Ginkgo biloba tree. Fluticasone propionate acts as an anti-inflammatory agent by binding to the glucocorticoid receptor and modulating gene expression to suppress inflammatory mediators. It is commonly used for asthma, allergic rhinitis, and various inflammatory skin conditions[2]. Ginkgo biloba extract contains terpene lactones (such as ginkgolides) and flavonoids with antioxidant and vasoactive properties; it has been studied for cognitive enhancement, neuroprotection, cardiovascular health, and other uses[1]. The combination may be intended to provide both anti-inflammatory effects (from fluticasone) and potential neuroprotective or circulatory benefits (from ginkgo), though there are no widely recognized approved indications for this specific combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluticasone propionate + ginkgo biloba extract.